explore -WSS

explore

author：focus 2025-09-27 16:36:35 - browse：27

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

entertainment

WSS

'Vaccine

Alnylam reports growth in sales of rare disease treatments

The a glaring gap in research on serious mental illness and primary care

5 ways to address the shortage of health care workers

Medicare slashes safety net hospital payments by nearly $1 billion

Redefining sustainability for the pharmaceutical industry

focus

explore

knowledge

23andMe had bad news about my health. I wish a person had delivered it

CDC panel: People 65 and older should get a Covid spring booster shot

23andMe had bad news about my health. I wish a person had delivered it

The a glaring gap in research on serious mental illness and primary care

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NEJM study measures Covid brain fog, impact on IQ

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A controversial new treatment promises to make little people taller

Peter Hotez and the public health issue of online harassment

Heart disease in astronauts blamed on cosmic radiation

focus

Readout Newsletter: Beam, Prozac, "TechBio" and more

Heart disease in astronauts blamed on cosmic radiation

FDA approves Sage Therapeutics’ rapid

Heart disease in astronauts blamed on cosmic radiation

Virtual repurposing can help discover new uses for existing drugs

Color Health wants to make cancer screenings convenient

entertainment

hotspot

explore

explore